Health Systems have the choice of two versions: light integration using electronic health record (EHR) resource links and a deeper integration that improves documentation and communicating within a health system. Both have complete coverage of described Mendelian disorders, as well as many non-genetic disorders in neurology & rheumatology.  They provide a simultaneous consult on a patient's diagnosis, helping to identify the likely differential diagnosis, key findings on which to comment and most useful tests, thereby lowering diagnostic errors and costs.

Each has advantages:

• Light integration through the EHR resource links. This combines institutional pre-permissioning of access to the SimulConsult diagnostic decision support software from tightly controlled clinical computers with institutional access that allows users to get going with just one click. Thousands of users familiar with the Classic version can use SimulConsult easily from clinical computers.


• Deep integration with the clinician workflow. This option is accessed from the patient record and saves user time and improves documentation and communicating within a health system.  It avoids duplication of effort by generating an editable note in the traditional medical SOAP format (either as a single unit or in sections to use with existing templates), and offers automated coding information.

• Clinicians can reopen SimulConsult with all patient findings already entered and add test results or other findings, thus enabling clinicians building on one another’s analysis
• The output creates an efficient way to communicate to radiology and genetic labs, avoiding both dictation of lengthy letters and loss of nuance in information.
• The output offers standardized structured data and diagnostic coding as ICD-9, ICD-10, SNOMED® or IMO® codes. Customers can set preferences such as whether to include diagnostic codes in notes or elsewhere.
• Deep integration can also be used with the Genome-Phenome Analyzer, and is particularly helpful in health systems where clinicians are involved in the clinical interpretation of the genomic findings.